Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
44.55 USD | -0.36% | +2.02% | -13.17% |
15/05 | US FDA approves expanded use of Bristol's cancer cell therapy | RE |
15/05 | Transcript : Bristol-Myers Squibb Company Presents at Bank of America Health Care Conference 2024, May-15-2024 11:20 AM |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.17% | 9.03TCr | |
+31.37% | 60TCr | |
-2.60% | 37TCr | |
+20.83% | 33TCr | |
+5.69% | 29TCr | |
+14.83% | 24TCr | |
+9.93% | 21TCr | |
-6.95% | 20TCr | |
+10.77% | 17TCr | |
+0.10% | 16TCr |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- BMO Capital Downgrades Bristol-Myers Squibb to Market Perform From Outperform, Cuts Price Target to $60 From $70